Opus Genetics CEO George Magrath, MD, discusses how the company introduced virtual reality-enabled assessments and relied on digital endpoints to better measure participants’ vision changes.
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
2023 Technology Adoption Trends And Plateaus
About 85% of industry leaders and managers have had some exposure to AI. Delve into the state of AI adoption experienced throughout 2023 and where the industry is headed concerning digital tool usage.
-
2024 MedTech Regulatory Updates: 4 Areas Of Interest
In 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.
-
What Is eCOA And How Does It Improve Clinical Trial Data Quality?
Discover how eCOA data capture can improve clinical trials by providing improved data quality, regulatory compliance, and accelerated clinical development.
-
Connecting The Right Patients To The Right Trial
Direct outreach to potential participants and communication with their healthcare providers is key to boosting trial awareness and participation, thereby achieving recruitment targets.
-
Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data
New, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.
-
Data Distortions: When Statistics Can Lead Us Astray In Drug Safety
Post-marketing signals and AE frequency comparisons need careful interpretation. Discover how confounding factors and misunderstood statistics often mislead drug safety professionals.
-
Why Your eTMF Needs Role-Based Access
Discover how role-based access controls can offer a way for clinical teams to answer the tough questions from regulators, investors, and other parties.
-
Digitizing Multilingual COAs: A Practical Guide
With pen and paper becoming obsolete in the digital era, shifting to electronic Clinical Outcome Assessments (eCOAs) is becoming more critical than ever. Download the available checklist for a guide through the four main steps required to ensure a successful English build and language migration.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech
Explore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.